Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Conditions: Malignant Rhabdoid Tumor; Rhabdoid Tumor of the Kidney; Epithelioid Sarcoma; Chordoma (Poorly Differentiated or De-differentiated); Atypical Teratoid/Rhabdoid Tumor; Other INI1 Negative Malignant Tumors (With PI Approval) Interventions: Drug: Nivolumab; Drug: Ipilimumab Sponsor: Dana-Farber Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Children | Chordoma | Research | Sarcomas | Study | Urology & Nephrology | Yervoy